MedPath

Piperacillin and Tazobactam

These highlights do not include all the information needed to use PIPERACILLIN AND TAZOBACTAM FOR INJECTION safely and effectively. See full prescribing information for PIPERACILLIN AND TAZOBACTAM FOR INJECTION. PIPERACILLIN and TAZOBACTAM for injection, for intravenous use Initial U.S. Approval: 1993

Approved
Approval ID

24d9b4f1-109c-4db4-8a99-03afff045b47

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2024

Manufacturers
FDA

Armas Pharmaceuticals Inc.

DUNS: 098405973

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Piperacillin and Tazobactam

PRODUCT DETAILS

NDC Product Code72485-403
Application NumberANDA065458
Marketing CategoryC73584
Route of AdministrationPARENTERAL, INTRAVENOUS
Effective DateJanuary 3, 2024
Generic NamePiperacillin and Tazobactam

INGREDIENTS (2)

PIPERACILLIN SODIUMActive
Quantity: 3 g in 15 mL
Code: M98T69Q7HP
Classification: ACTIM
TAZOBACTAM SODIUMActive
Quantity: 0.375 g in 15 mL
Code: UXA545ABTT
Classification: ACTIM
© Copyright 2025. All Rights Reserved by MedPath
Piperacillin and Tazobactam - FDA Approval | MedPath